Dr Nita Patel, director of antibody discovery and vaccine development, lifts a vaccine vial at Novavax’s  labs in Maryland. Photograph:  Andrew Caballero-Reynolds/AFP via Getty Images

Novavax’s Covid-19 vaccine was 90 per cent effective in its late stage trial in the US and Mexico and proved it can tackle the virus variants of conce(...)

About 300,000 vaccine doses  were administered last week, with a similar amount expected to be done next week. Photograph: Brian Lawless/PA Wire

The HSE will later this week outline the next phase of the State’s vaccination plan which will see more than 400,000 shots a week administered in June(...)

The National Immunisation Advisory Committee (NIAC) has approved the use of  the Johnson and Johnson (Janssen)  vaccine and relaxed its restrictions on the AstraZeneca shot. Photograph: EPA

The State’s Covid-19 vaccination programme received a double boost last night when the National Immunisation Advisory Committee (NIAC) gave the go-ahe(...)

Johnson & Johnson’s Covid-19 vaccine is safe and effective, US regulators said, a key milestone on the path toward approving access for the first such shot to work in a single dose. Photograph:  Justin Tallis/AFP via Getty Images

Johnson & Johnson’s Covid-19 vaccine is safe and effective, US regulators said, a key milestone on the path toward approving access for the first (...)

In the coming weeks FDA officials will examine Johnson and Johnson’s trial data.

Johnson and Johnson asked US drug regulators to clear its experimental Covid-19 vaccine for emergency use, setting off a review process that could lea(...)

The European Medicines Agency has cleared three vaccines.

Johnson & Johnson will ship some Covid-19 vaccines ordered by the European Union to the US for the last stage of production, raising concern among(...)

US pharma companies Moderna and Pfizer, with its German partner BioNTech have launched major Phase III trials of their Covid vaccine candidates. Photograph: Hans Pennink/AP

German biotech BioNTech and US drugmaker Pfizer will begin a pivotal global study of 30,000 people to evaluate their lead Covid-19 vaccine candidate. (...)

JandJ, already the world’s biggest maker of healthcare products, is fulfilling its goal of adding a new drug category

Johnson and Johnson (JandJ) has agreed to buy Actelion for $30 billion (€28.1bn), clinching one of its largest ever deals to become a leader in medici(...)

The headquarters of Swiss biotech company Actelion in Allschwil, Switzerland. Photograph: Arnd Wiegmann/File Photo/Reuters

In a surprise twist to one of 2016’s biggest potential health deals, Actelion and US drug giant Johnson and Johnson are back at the negotiating table (...)

Depuy Synthes, a manufacturer of orthopaedic products, is to create 80 new jobs at its manufacturing plant in Cork. The move coincides with the offici(...)

  • 1
  • 2
  • Next
  • Last »